Brainstorm Cell Therapeutics Inc (BCLI) — Cash Flow Quality Index

Latest as of December 2017: -10.63x

Brainstorm Cell Therapeutics Inc (BCLI) has a Cash Flow Quality Index of -10.63x as of December 2017. Operating cash flow of $-2.94 Million is below net income of $276.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Brainstorm Cell Therapeutics Inc (BCLI) long-term investment share to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-10.63x

Operating CF / Net Income

Operating Cash Flow

$-2.94 Million

USD

Net Income

$276.00K

USD

Data as of

Dec 2017

Most recent filing

Annual Cash Flow Quality Index for Brainstorm Cell Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Brainstorm Cell Therapeutics Inc. For live market cap and the full company financial profile, see BCLI company net worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.